Будь ласка, зачекайте, ми завантажуємо дані графіка
AstraZeneca PLC спільнота
About AstraZeneca PLC
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 8 660,85 ₴, with a 24-hour trading volume of 0 ₴. The asset's market cap is 13,43T ₴, after moving -0.64% in the last day.
Tokenized AstraZeneca PLC is trading at 4 400,57 ₴, with a tokenized market cap of 2,49B ₴ and a 24-hour trading volume of 37,78M ₴. The tokenized asset has moved -11.22% in the past 24 hours.